When to publish measures of disproportionality derived from spontaneous reporting databases?

doi:10.1111/j.1365-2125.2011.04087.x

Comment

. 2011 Dec;72(6):909-11.

doi: 10.1111/j.1365-2125.2011.04087.x.

When to publish measures of disproportionality derived from spontaneous reporting databases?

Anthonius de Boer¹

Affiliations

PMID: 21848575
PMCID: PMC3244637
DOI: 10.1111/j.1365-2125.2011.04087.x

Comment

When to publish measures of disproportionality derived from spontaneous reporting databases?

Anthonius de Boer. Br J Clin Pharmacol. 2011 Dec.

. 2011 Dec;72(6):909-11.

doi: 10.1111/j.1365-2125.2011.04087.x.

Author

Anthonius de Boer¹

Affiliation

¹ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands. a.deboer@uu.nl

PMID: 21848575
PMCID: PMC3244637
DOI: 10.1111/j.1365-2125.2011.04087.x

No abstract available

PubMed Disclaimer

Comment on

Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.
Chavant F, Favrelière S, Lafay-Chebassier C, Plazanet C, Pérault-Pochat MC. Chavant F, et al. Br J Clin Pharmacol. 2011 Dec;72(6):898-904. doi: 10.1111/j.1365-2125.2011.04009.x. Br J Clin Pharmacol. 2011. PMID: 21557759 Free PMC article.

Cited by

Two cheers or three for treatment guidelines? Nudging prescribers in right directions.
Loke YK, Ritter JM. Loke YK, et al. Br J Clin Pharmacol. 2011 Dec;72(6):869-70. doi: 10.1111/j.1365-2125.2011.04122.x. Br J Clin Pharmacol. 2011. PMID: 22070575 Free PMC article. No abstract available.
Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).
Aldea Perona A, García-Sáiz M, Sanz Álvarez E. Aldea Perona A, et al. Drug Saf. 2016 Jan;39(1):69-78. doi: 10.1007/s40264-015-0360-2. Drug Saf. 2016. PMID: 26620206
Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
Raschi E, Poluzzi E, Koci A, Salvo F, Pariente A, Biselli M, Moretti U, Moore N, De Ponti F. Raschi E, et al. Br J Clin Pharmacol. 2015 Aug;80(2):285-93. doi: 10.1111/bcp.12611. Epub 2015 May 20. Br J Clin Pharmacol. 2015. PMID: 25689417 Free PMC article.
Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System.
Naganuma M, Tahara K, Hasegawa S, Fukuda A, Sasaoka S, Hatahira H, Motooka Y, Nakao S, Mukai R, Hirade K, Yoshimura T, Kato T, Takeuchi H, Nakamura M. Naganuma M, et al. SAGE Open Med. 2019 Mar 11;7:2050312119836011. doi: 10.1177/2050312119836011. eCollection 2019. SAGE Open Med. 2019. PMID: 30886713 Free PMC article.
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system.
Zhu C, Cui Z, Liu T, Lou S, Zhou L, Chen J, Zhao R, Wang L, Ou Y, Zou F. Zhu C, et al. Front Pharmacol. 2025 Mar 12;16:1531514. doi: 10.3389/fphar.2025.1531514. eCollection 2025. Front Pharmacol. 2025. PMID: 40144660 Free PMC article.

See all "Cited by" articles

References

1. Chavant F, Favrelière S, Lafay-Chebassier C, Plzanet C, Pérault-Pochat MC. Memory disorders associated with drugs consumption: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011 May 10. doi: 10.1111/j.1365-2125.2011.04009.x. [Epub ahead of print] - DOI - PMC - PubMed
1. Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. - PubMed
1. Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases. The notoriety bias. Drug Saf. 2007;30:891–8. - PubMed
1. Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14:285–6. - PubMed
1. Pariente A, Didailler M, Avillach P, Miremont-Salamé F, Moore N. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2010;19:1166–71. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Chavant F, Favrelière S, Lafay-Chebassier C, Plzanet C, Pérault-Pochat MC. Memory disorders associated with drugs consumption: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011 May 10. doi: 10.1111/j.1365-2125.2011.04009.x. [Epub ahead of print] - DOI - PMC - PubMed

[2] Chavant F, Favrelière S, Lafay-Chebassier C, Plzanet C, Pérault-Pochat MC. Memory disorders associated with drugs consumption: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011 May 10. doi: 10.1111/j.1365-2125.2011.04009.x. [Epub ahead of print] - DOI - PMC - PubMed

[3] Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. - PubMed

[4] Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. - PubMed

[5] Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases. The notoriety bias. Drug Saf. 2007;30:891–8. - PubMed

[6] Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases. The notoriety bias. Drug Saf. 2007;30:891–8. - PubMed

[7] Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14:285–6. - PubMed

[8] Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14:285–6. - PubMed

[9] Pariente A, Didailler M, Avillach P, Miremont-Salamé F, Moore N. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2010;19:1166–71. - PubMed

[10] Pariente A, Didailler M, Avillach P, Miremont-Salamé F, Moore N. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2010;19:1166–71. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

When to publish measures of disproportionality derived from spontaneous reporting databases?

Affiliation

When to publish measures of disproportionality derived from spontaneous reporting databases?

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical